Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16021071 | 0.86 | ALDH1A1 (0.44) | ALDH1A1MTNR1ALMNASMN1; SMN2NPC1 | |
| SCHEMBL24898332 | 0.85 | LMNA (0.47) | ALDH1A1LMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL13789085 | 0.84 | MTNR1A (0.38) | ALDH1A1MTNR1ALMNASMN1; SMN2NPC1 | |
| SCHEMBL8635741 | 0.83 | LMNA (0.42) | ALDH1A1MTNR1ALMNASMN1; SMN2NPC1 | |
| SCHEMBL11963897 | 0.81 | MTNR1A (0.44) | ALDH1A1MTNR1ALMNASMN1; SMN2NPC1 | |
| SCHEMBL17343016 | 0.81 | ALDH1A1 (0.44) | ALDH1A1MTNR1ALMNASMN1; SMN2RAB9A | |
| SCHEMBL368273 | 0.80 | LMNA (0.57) | ALDH1A1LMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL6825744 | 0.80 | ALDH1A1 (0.35) | ALDH1A1LMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL5160066 | 0.79 | CA2 (0.50) | ALDH1A1MTNR1ANPSR1 | |
| SCHEMBL2863034 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115177793-A | Method for modifying mussel protein-polyglutamic acid antibacterial lubricating medical hydrogel coating on surface of base material | 南京工业大学 | 2022-10-14 | — | — | CN | claimed |
| EP-3119829-B1 | CONTROLLED CROSSLINKING OF LATEX POLYMERS WITH POLYFUNCTIONAL AMINES | ENNIS PAINT INC (US) | 2020-08-19 | — | — | EP | claimed |
| US-10717800-B2 | Controlled crosslinking of latex polymers with polyfunctional amines | ENNIS PAINT, INC. (US) | 2020-07-21 | — | — | US | claimed |
| CN-106536590-B | Controlled crosslinking of latex polymers with polyfunctional amines | 恩尼斯涂料有限公司 | 2020-06-09 | — | — | CN | claimed |
| EP-3510108-A1 | WATERBORNE COPOLYMER DISPERSIONS WITH IMPROVED WET SCRUB RESISTANCE | Celanese International Corporation (US) | 2019-07-17 | — | — | EP | claimed |
| CN-109790397-A | With the aqueous copolymer dispersion for improving scrub performance | 国际人造丝公司 | 2019-05-21 | — | — | CN | claimed |
| CN-109293523-A | A kind of ionic cross-linking monomer, Its Preparation Method And Use | 世晟博（深圳）科技有限公司 | 2019-02-01 | — | — | CN | claimed |
| US-10081757-B2 | Shale swelling inhibitors | ISP INVESTMENTS LLC (US) | 2018-09-25 | — | — | US | claimed |
| CN-105431589-B | Copolymer dispersion and their purposes in paper painting preparation | 塞拉尼斯销售德国有限公司 | 2018-05-15 | — | — | CN | claimed |
| US-9920483-B2 | Copolymer dispersions and their use in paper-coating formulations | CELANESE SALES GERMANY GMBH (DE) | 2018-03-20 | — | — | US | claimed |
| US-20150259562-A1 | Controlled Crosslinking of Latex Polymers With Polyfunctional Amines | FLINT TRADING INC. | 2015-09-17 | — | — | US | claimed |
| US-8999309-B2 | Hair preparation containing two copolymers | HENKEL AG & CO. KGAA (DE) | 2015-04-07 | — | — | US | claimed |
| WO-2014204779-A1 | COPOLYMER DISPERSIONS AND THEIR USE IN PAPER-COATING FORMULATIONS | CELANESE EMULSIONS GMBH (DE) | 2014-12-24 | — | — | WO | claimed |
| WO-2014204777-A2 | COPOLYMER DISPERSIONS AND THEIR USE IN PAPER-COATING FORMULATIONS | CELANESE EMULSIONS GMBH (DE) | 2014-12-24 | — | — | WO | claimed |
| WO-2014088850-A2 | SHALE SWELLING INHIBITORS | ISP INVESTMENTS INC. (US) | 2014-06-12 | — | — | WO | claimed |
| CN-101965369-A | Molar ratio change for larger polyolefin catalysts | BASF CATALYSTS LLC | 2011-02-02 | — | — | CN | claimed |
| US-20100189678-A1 | Hair Preparation Containing Two Copolymers | HENKEL AG & CO. KGAA | 2010-07-29 | — | — | US | claimed |
| US-20080234433-A1 | CATALYZED MULTIPLE GRAFTING POLYMERIZATIONS | THE UNIVERSTIRY OF CONNECTICUT | 2008-09-25 | — | — | US | claimed |
| EP-0951496-B1 | ALKYD AND ARALKYD DERIVATIVES OF PHENOLIC POLYMERS | GEORGIA PACIFIC RESINS (US) | 2001-12-19 | — | — | EP | claimed |
| US-5710211-A | REACTION OF POLYMER WITH COMPOUND HAVING A THIOL OR THIOESTER AND HYDROLYSIS TO FORM VINYL ALCOHOL | KURARAY CO., LTD. (JP) | 1998-01-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10717800-B2 | Controlled crosslinking of latex polymers with polyfunctional amines | ALG1, LTA, LTN1 | ALDH1A1 1969/4885MTNR1A 4834/4885LMNA 151/4885 |
| US-20150259562-A1 | Controlled Crosslinking of Latex Polymers With Polyfunctional Amines | ALG1, LTA, LTN1 | ALDH1A1 1969/4885MTNR1A 4834/4885LMNA 151/4885 |
| US-20100189678-A1 | Hair Preparation Containing Two Copolymers | ASS1, ACR, SMS | ALDH1A1 277/4885MTNR1A 81/4885LMNA 675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.